IDN 5390
Phase 1- Indications
- Cancer
Company intelligence / Profile preview
Indena is a global leader in the identification, development, and production of high-quality active principles from plants. The company supplies standardized botanical extracts and active pharmaceutical ingredients to the pharmaceutical, nutraceutical/health food, and personal care industries. Its proprietary Phytosome® technology enhances bioavailability of natural compounds. Indena’s portfolio includes well-known APIs such as paclitaxel and docetaxel for oncology; galantamine for Alzheimer’s disease; cytisine for smoking cessation; plus a wide range of standardized herbal extracts targeting cardiovascular health, CNS conditions, metabolic syndrome prevention/treatment among others. The company operates globally with manufacturing sites compliant with cGMP standards.
4 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Indena.